Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy1

Racusen, 1999, The Banff 97 working classification of renal allograft pathology, Kidney Int, 55, 713, 10.1046/j.1523-1755.1999.00299.x

Paul, 2001, Immunologic risk factors for chronic renal allograft dysfunction, Transplantation, 71, SS1

Fellström, 2001, Nonimmune risk factors for chronic renal allograft dysfunction, Transplantation, 71, SS10

Russell, 1994, Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity, J Immunol, 152, 5135

Scornik, 1989, Posttransplant antidonor antibodies and graft rejection: evaluation by two-color flow cytometry, Transplantation, 47, 287, 10.1097/00007890-198902000-00018

Saiki, 1989, Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes, Proc Natl Acad Sci USA, 86, 6230, 10.1073/pnas.86.16.6230

Pei, 1998, Simultaneous HLA class I and class II antibodies screening with flow cytometry, Hum Immunol, 59, 313, 10.1016/S0198-8859(98)00020-2

Bray, 1994, Flow cytometry crossmatching for solid organ transplantation, Methods Cell Biol, 41, 103, 10.1016/S0091-679X(08)61712-4

Brando, 1996, Flow cytometry cross-match, Eur J Histochem, 40, 53

Martin, 1987, Posttransplant anti-donor lymphocytotoxic antibody production in relation to graft outcome, Transplantation, 44, 50, 10.1097/00007890-198707000-00012

Christiaans, 2000, Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation, Transplantation, 69, 917, 10.1097/00007890-200003150-00043

Piazza, 2001, Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplantation analysis using flow cytometric techniques, Transplantation, 71, 1106, 10.1097/00007890-200104270-00017

Abe, 1997, Postoperative production of anti-donor antibody and chronic rejection in renal transplantation, Transplantation, 63, 1616, 10.1097/00007890-199706150-00014

McKenna, 2000, Anti-HLA antibodies after solid organ transplantation, Transplantation, 69, 319, 10.1097/00007890-200002150-00001

McMahon, 2000, Polyreactivity as an acquired artefact, rather than physiologic property of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH, J Immunol Methods, 241, 1, 10.1016/S0022-1759(00)00196-4

Mauiyyedi, 2001, Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries, J Am Soc Nephrol, 12, 574, 10.1681/ASN.V123574

Ferry, 1997, Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection, Transplant Immunol, 5, 17, 10.1016/S0966-3274(97)80021-4

Ball, 2000, Antibodies to vascular endothelial cells in chronic rejection of renal allografts, Transplant Proc, 32, 353, 10.1016/S0041-1345(99)00976-8

Halloran, 1990, Significance of anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection, Transplantation, 49, 85, 10.1097/00007890-199001000-00019

Russell, 1997, Alloantibody and T-cell mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice, Transplantation, 64, 1531, 10.1097/00007890-199712150-00005

Cramer, 1998, The importance of humoral immune response in chronic rejection, Transpl Rev, 12, 166, 10.1016/S0955-470X(98)80007-4

Shirwan, 1999, Chronic allograft rejection. Do the TH2 cells preferentially induced by indirect allorecognition play a dominant role?, Transplantation, 68, 715, 10.1097/00007890-199909270-00001

Theruvath, 2001, Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection, Transplantation, 72, 77, 10.1097/00007890-200107150-00016